HACCP certification – Preventive Hazard Analysis for Highest Safety Standards

Last updated: 02. March 2026

The application of HACCP principles ensures that companies, during the production or processing of products, identify, control, and minimize biological, chemical, and physical hazards through systematic hygiene management (HACCP - Hazard Analysis and Critical Control Points). This systematic procedure focuses primarily on preventive measures.

The concept originally stems from the food industry and has since become an integral part of quality risk management (according to ICH Q9) within the GMP framework in the pharmaceutical industry. In modern aseptic production, HACCP also forms a fundamental pillar of the Contamination Control Strategy (CCS) according to EU-GMP Annex 1. While HACCP defines the critical control points, the CCS bundles all technical and organizational measures—from facility planning to personnel behavior—into a holistic protection concept. This is because even minor microbiological irregularities in pharmaceuticals can have serious consequences for patients. The HACCP method serves as a tool to systematically increase production safety.

 

Process of the HACCP Methodology in Production

The process follows seven principles:

  1. Hazard Analysis: Identification of potential biological, chemical, or physical risks (e.g., particles or germs).
  2. Determination of Critical Control Points (CCPs): Establishing process steps where a hazard can be reliably controlled.
  3. Establishment of Action and Warning Limits: Definition of measurable and validated parameters (e.g., sterilization temperature, integrity of sterile filtration, or critical process times).
  4. Monitoring of CCPs: Use of a continuous monitoring system integrated into the equipment control, which detects deviations in real time.
  5. Establishment of Corrective Actions (CAPA): Definition of steps in the event of limit deviations to ensure product conformity.
  6. Verification: Regular review of the effectiveness of the HACCP system (e.g., through regular process assessments and hygiene monitoring).
  7. Documentation: Seamless recording of all data in a tamper-proof audit trail.

Regular controls must be documented. If a limit is reached, validated corrective measures take effect immediately. This seamless documentation serves as proof of the functionality of the entire system to regulatory authorities such as the FDA or EMA.

 

Application and Regulatory Relevance

The application of HACCP principles is legally mandated in the food industry. In the pharmaceutical industry, it is an essential part of the Contamination Control Strategy (CCS) according to EU-GMP Annex 1. Compliance is confirmed here by the GMP certificate of the production site; a separate "HACCP certificate" is uncommon in pharmaceutical production.

The following industries utilize HACCP principles:

  • Pharmaceutical Industry & Biotechnology: Control of contamination in parenterals and biologics.
  • Medical Technology: Ensuring the sterility of critical components.
  • Cosmetics Manufacturers: Protection against microbiological spoilage without excessive preservation.
  • Food Industry: Compliance with EU Regulation 852/2004.

 

Goals of the HACCP Method

The main goal is to guarantee maximum product safety through prevention instead of retrospective quality control. In detail, this means:

  • Hazard Control: Early detection and elimination of microbiological germs, particles, or chemical cross-contamination.
  • Legal Certainty (Compliance): Fulfillment of international cGMP requirements.
  • Traceability: Transparent monitoring of all process-relevant measures.

 

Advantages and Disadvantages of the HACCP Concept

Advantages:

  • Increased Product Safety: Significant reduction of contamination risks.
  • Optimization of Processes: Deep understanding of critical process phases.
  • Trust: Proof of the highest standards to customers in the field of contract manufacturing (CDMO).
  • Highest Process Integrity: Blow-Fill-Seal (BFS) technology significantly minimizes the number of critical control points (CCPs) compared to conventional filling lines, as forming, filling, and sealing occur in a single, closed system without human intervention.

Challenges: Implementation requires initial effort for risk analyses and investments in precise sensor technology. However, by avoiding batch losses and recalls, these costs amortize quickly. Furthermore, the high degree of automation in BFS technology leads to a significant reduction in personnel deployment in the critical zone (Class A), which not only lowers personnel costs but almost completely eliminates the primary contamination risk of the HACCP analysis - the human factor - from the process side.